Evolution of the Average Target: Forvia (ex-Faurecia)

Evolution of the Target Price: Forvia (ex-Faurecia)

Changes in Analyst Recommendations: Forvia (ex-Faurecia)

7075.4_dvEcXKHaGRDIz4q294FTE7X9aajH0eorwbTsER4ZQ.18YuefymUumjOciZ7VopYERqbozxyxdf8skseopag96zlQl0pokkz6c8vA~283989c213596656472ef9a92fd162a7
FORVIA : Target cut by -45.6% Alphavalue
FORVIA : Solid H1 results; guidance lowered amid a challenging market outlook Alphavalue
Stifel Downgrades Forvia to Hold from Buy, Cuts PT MT
FORVIA : Stifel downgrades its recommendation CF
FORVIA : Solid Q1 results with strong organic growth offset by unfavorable exchange rates Alphavalue
FORVIA : UBS upgrades to Buy on the stock CF
FORVIA : Berenberg reduces its target price CF
FORVIA : Solid FY23 results, but concerns over weakening European demand and Asian dependency Alphavalue
FORVIA : HSBC reduces target, but reiterates buy recommendation CF
FORVIA : Deutsche Bank lowers its target price CF
Forvia: up sharply after positive analysis CF
Forvia: share price boosted by double upgrade from Barclays CF
FORVIA : Barclays upgrades to 'overweight CF
FORVIA : Welcoming a framed extension to the divestment plan Alphavalue
FORVIA : FY23 guidance upgrade lacks traction in the face of high expectations Alphavalue
Berenberg Raises Forvia PT, Maintains Buy Recommendation MT
FORVIA : Berenberg raises its target price CF
Forvia: share price advances, analyst sees potential CF
Stifel Maintains Forvia at Buy, Boosts PT MT
Forvia: supported by broker's comments CF
FORVIA : Stifel raises its target price CF
FORVIA : Share count adjustment, raised debt charges, and H1 23 preview Alphavalue
FAURECIA : Jefferies raises its recommendation CF
Faurecia: broker upgrades recommendation to 'buy CF
Welcome clarity on the Symbio deal, short of our valuation but contributing fresh cash Alphavalue
More recommendations

Add to a list
Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+125.32%
+44.12%
+34.21%
+16.52%
+0.59%
+28.38%
+69.77%
+24.36%
+42.98%
Average +42.92%
Weighted average by Cap. +35.13%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
8.538EUR
Average target price
19.24EUR
Spread / Average Target
+125.32%
High Price Target
39.00EUR
Spread / Highest target
+356.78%
Low Price Target
12.00EUR
Spread / Lowest Target
+40.55%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Adrien Brasey
Stifel Nicolaus
Berenberg Bank
GOLDMAN SACHS Philipp Konig
JEFFERIES Himanshu Agarwal
UBS David Lesne
DEUTSCHE BANK RESEARCH Christoph Laskawi
JPMORGAN Jose Asumendi
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. FRVIA Stock
  4. Consensus Forvia (ex-Faurecia)
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW